Medication Guide App

Gefitinib

In the US, Gefitinib (gefitinib systemic) is a member of the drug class EGFR inhibitors and is used to treat Non-Small Cell Lung Cancer.

US matches:

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

L01XE02

CAS registry number (Chemical Abstracts Service)

0184475-35-2

Chemical Formula

C22-H24-Cl-F-N4-O3

Molecular Weight

446

Therapeutic Category

Cytostatic agent: Epidermal growth factor receptor tyrosine kinase inhibitor

Chemical Names

4-Quinazolinamine, N-(3-chloro-4-fluorophenyl)-7-methoxy-6-[3-(4-morpholin)propoxy]- (USAN)

N-(3-Chlor-4-fluorphenyl)-7-methoxy-6-[3-(morpholin-4-yl)propoxy]chinazolin-4-amin (IUPAC)

N-(3-chloro-4-fluorophenyl)-7-methoxy-6-[3-(morpholin-4-yl)propoxy]quinazolin-4-amine (WHO)

Foreign Names

  • Gefitinibum (Latin)
  • Gefitinib (German)
  • Gefitinib (French)
  • Gefitinib (Spanish)

Generic Names

  • Gefitinib (OS: USAN, BAN)
  • ZD 1839 (IS)

Brand Names

  • Gefonib
    Miracalus, India
  • Geftib
    Glenmark, India
  • Iressa
    AstraZeneca, Argentina; AstraZeneca, Austria; AstraZeneca, Australia; AstraZeneca, Belgium; AstraZeneca, Bahrain; AstraZeneca, Canada; AstraZeneca, Chile; AstraZeneca, China; AstraZeneca, Germany; AstraZeneca, Denmark; AstraZeneca, Spain; AstraZeneca, Finland; AstraZeneca, France; AstraZeneca, United Kingdom; AstraZeneca, Greece; AstraZeneca, Hong Kong; AstraZeneca, Croatia (Hrvatska); AstraZeneca, Indonesia; AstraZeneca, Israel; AstraZeneca, Iceland; AstraZeneca, Italy; AstraZeneca, Japan; AstraZeneca, South Korea; AstraZeneca, Lithuania; AstraZeneca, Mexico; AstraZeneca, Malaysia; AstraZeneca, Norway; AstraZeneca, New Zealand; AstraZeneca, Philippines; AstraZeneca, Poland; AstraZeneca, Portugal; AstraZeneca, Serbia; AstraZeneca, Sweden; AstraZeneca, Singapore; AstraZeneca, Slovenia; AstraZeneca, Thailand; AstraZeneca, Taiwan
  • IRESSA
    AstraZeneca, Switzerland; AstraZeneca, Latvia

International Drug Name Search

Glossary

TermDefinition
BANBritish Approved Name
IUPACInternational Union of Pure and Applied Chemistry
ISInofficial Synonym
OSOfficial Synonym
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name
WHOWorld Health Organization

Click for further information on drug naming conventions and International Nonproprietary Names.

Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Hide
(web1)